CXW

In the past six months, CoreCivic's stock price increased by approximately 67% to 67.5%. Key events include the company reporting strong second-quarter 2026 results with EPS of $0.38 surpassing estimates and revenue increasing by 27.3% year-over-year to $684.9 million, leading to updated full-year 2026 diluted EPS guidance. CoreCivic completed the sale of several detention facilities, generating approximately $1.6 billion in net proceeds, which were used for debt reduction and a board-authorized share buyback program initially of $500 million, later increased to $1.2 billion. Patrick Swindle resigned as CEO for health reasons, and Lucibeth Mayberry was named as his successor, causing some stock volatility despite her commitment to the current capital allocation strategy. California's new 25% tax on detention operators has created an overhang, though analysts expect a potential challenge from the Department of Justice. On April 1, 2026, CoreCivic acquired Clinical Solutions Pharmacy (CSP), a major provider of mail-order pharmacy services to correctional facilities in the U.S.